Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | GAA | P10253 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.72 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.72 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.72 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.72 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.65 |
| ▸ | HTT | P42858 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | TLR4 | O00206 | 1/20 | 0.56 |
| ▸ | TLR2 | O60603 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.52 |
| ▸ | SRC | P12931 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL27888748 | 1.00 | LMNA (1.00) | LMNAKMT2AGAAALDH1A1CYP1A2 | |
| SCHEMBL29361707 | 1.00 | LMNA (1.00) | LMNAKMT2AGAAALDH1A1CYP1A2 | |
| SCHEMBL31241187 | 0.96 | LMNA (0.92) | LMNAKMT2AGAAALDH1A1CYP1A2 | |
| SCHEMBL31599176 | 0.93 | LMNA (0.88) | LMNAKMT2AGAAALDH1A1CYP1A2 | |
| Sulfurous Acid SCHEMBL11210033 | 0.91 | LMNA (0.82) | LMNAKMT2AGAAALDH1A1CYP1A2 | |
| Sulfurous Acid SCHEMBL11525327 | 0.89 | LMNA (0.79) | LMNAKMT2AGAAALDH1A1CYP1A2 | |
| SCHEMBL31241184 | 0.88 | LMNA (0.79) | LMNAKMT2AGAAALDH1A1CYP1A2 | |
| SCHEMBL4434944 | 0.86 | LMNA (0.75) | LMNAKMT2AGAAALDH1A1CYP1A2 | |
| SCHEMBL23036030 | 0.86 | LMNA (0.75) | LMNAKMT2AGAAALDH1A1CYP1A2 | |
| SCHEMBL1201051 | 0.86 | LMNA (0.75) | LMNAKMT2AGAAALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 797 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250059209-A1 | THERAPEUTIC AGENTS AND USES THEREOF | ANKH LIFE SCIENCES LIMITED (IE) | 2025-02-20 | — | — | US | claimed |
| CN-116354801-A | Synthesis method for pyriproxyfen intermediate | 如东众意化工有限公司 | 2023-06-30 | — | — | CN | claimed |
| EP-4185288-A1 | THERAPEUTIC AGENTS AND USES THEREOF | Ankh Life Sciences Limited (IE) | 2023-05-31 | — | — | EP | claimed |
| CN-115916195-A | Therapeutic agents and uses thereof | 安科生命科学有限公司 | 2023-04-04 | — | — | CN | claimed |
| US-20220033417-A1 | THERAPEUTIC AGENTS AND USES THEREOF | ANKH LIFE SCIENCES LIMITED (IE) | 2022-02-03 | — | — | US | claimed |
| WO-2022019892-A1 | THERAPEUTIC AGENTS AND USES THEREOF | ANKH LIFE SCIENCES LIMITED (IE) | 2022-01-27 | — | — | WO | claimed |
| CN-112824438-A | Novel synthesis method of polyimide | 湘潭大学 | 2021-05-21 | — | — | CN | claimed |
| CN-106032543-B | Method for preparing S-cyanohydrin | 弈柯莱生物科技(上海)股份有限公司 | 2021-03-19 | — | — | CN | claimed |
| CN-109776338-A | Salan ligand, metal-Salan complex and prepare chiral alpha-hydroxy-beta -one ester compound method | 济南大学 | 2019-05-21 | — | — | CN | claimed |
| CN-105441065-B | Detect fluorescence probe of hypochlorite ion and preparation method thereof and application method | 浙江理工大学 | 2018-05-25 | — | — | CN | claimed |
| US-4402804-A | Electrolytic synthesis of aryl alcohols, aryl aldehydes, and aryl acids | PPG INDUSTRIES, INC. (US) | 1983-09-06 | — | — | US | claimed |
| US-4382894-A | Production of α-cyanobenzyl esters | CIBA-GEIGY CORPORATION (US) | 1983-05-10 | — | — | US | claimed |
| EP-0025925-B1 | PROCESS FOR THE PREPARATION OF ALPHA-CYANO-PHENOXY BENZYLIC ESTERS | BAYER AG (DE) | 1983-02-09 | — | — | EP | claimed |
| EP-0064658-A1 | Substituted phenoxybenzaldehyde acetals, process for their preparation and their use as herbicides and plant growth regulators | BAYER AG (DE) | 1982-11-17 | — | — | EP | claimed |
| EP-0001064-B1 | FLUOROSUBSTITUTED PHENOXYBENZYL-OXYCARBONYLDERIVATIVES, -ALCOHOLS AND -HALIDES, PROCESSES FOR THEIR PREPARATION AND THEIR APPLICATION | BAYER AG (DE) | 1982-07-07 | — | — | EP | claimed |
| EP-0053321-A2 | Substituted derivatives of phenoxy cinnamic acid, process for their preparation and their use as herbicides | BAYER AG (DE) | 1982-06-09 | — | — | EP | claimed |
| EP-0052836-A1 | Phenoxybenzaldehydes and process for their preparation | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-06-02 | — | — | EP | claimed |
| EP-0049577-A1 | Alpha-cyanophenoxybenzylamine derivatives, processes for preparing them, and their use as intermediates for the preparation of pyrethroid insecticides | ICI AUSTRALIA LIMITED (AU) | 1982-04-14 | — | — | EP | claimed |
| EP-0021868-B1 | PROCESS FOR THE PREPARATION OF DIARYL ETHERS | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1981-12-23 | — | — | EP | claimed |
| US-4199527-A | Removal of ketene impurities in the preparation of alpha-cyano-aryloxybenzyl alcohols | SHELL OIL COMPANY (US) | 1980-04-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250059209-A1 | THERAPEUTIC AGENTS AND USES THEREOF | MCL1, RNASE1, HNMT | LMNA 514/4885KMT2A 226/4885GAA 752/4885 |
| US-20220033417-A1 | THERAPEUTIC AGENTS AND USES THEREOF | MCL1, BCL9, RNASE1 | LMNA 692/4885KMT2A 249/4885GAA 486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.